PHARMACYTE BIOTECH, INC. Operating Cash Flow
PHARMACYTE BIOTECH, INC. (PMCB) reported Operating Cash Flow of -$780.89 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-07-31 was -$780.89K.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-04-30 was -$1.39M.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-01-31 was -$786.85K.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) operating activities for the quarter ending 2025-10-31 was -$979.52K.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) operating activities for fiscal 2026 was -$5.15M.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$2.98M.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$2.15M.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$3.79M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$780.89K 10-Q · filed 2026-09-14 | -$2.17M derived: sum of 2 quarters · filed 2026-09-14 | -$2.96M derived: sum of 3 quarters · filed 2026-09-14 | -$3.94M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$2.18M derived: sum of 2 quarters · filed 2026-07-29 | -$3.16M derived: sum of 3 quarters · filed 2026-07-29 | -$5.15M 10-K · filed 2026-07-29 |
| 2026-01-31 | -$786.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -$1.77M derived: sum of 2 quarters · filed 2026-03-17 | -$3.76M 10-Q · filed 2026-03-17 | -$4.80M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | -$979.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-18 | -$2.97M 10-Q · filed 2025-12-18 | -$4.01M derived: sum of 3 quarters · filed 2026-09-14 | -$4.52M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | -$1.99M 10-Q · filed 2026-09-14 | -$3.03M derived: sum of 2 quarters · filed 2026-09-14 | -$3.54M derived: sum of 3 quarters · filed 2026-09-14 | -$4.60M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$1.55M derived: sum of 2 quarters · filed 2026-07-29 | -$2.60M derived: sum of 3 quarters · filed 2026-07-29 | -$2.98M 10-K · filed 2026-07-29 |
| 2025-01-31 | -$509.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -$1.56M derived: sum of 2 quarters · filed 2026-03-17 | -$1.94M 10-Q · filed 2026-03-17 | -$2.27M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-10-31 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-18 | -$1.43M 10-Q · filed 2025-12-18 | -$1.76M derived: sum of 3 quarters · filed 2025-12-18 | -$1.94M derived: sum of 4 quarters · filed 2025-12-18 |
| 2024-07-31 | -$373.30K 10-Q · filed 2025-09-15 | -$706.25K derived: sum of 2 quarters · filed 2025-09-15 | -$883.36K derived: sum of 3 quarters · filed 2025-09-15 | -$2.87M derived: sum of 4 quarters · filed 2025-09-15 |
| 2024-04-30 | -$332.96K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | -$510.06K derived: sum of 2 quarters · filed 2025-08-11 | -$2.49M derived: sum of 3 quarters · filed 2025-08-11 | -$2.15M 10-K · filed 2025-08-11 |
| 2024-01-31 | -$177.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | -$2.16M derived: sum of 2 quarters · filed 2025-03-17 | -$1.82M 10-Q · filed 2025-03-17 | -$2.11M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-13 | -$1.64M 10-Q · filed 2024-12-13 | -$1.93M derived: sum of 3 quarters · filed 2024-12-13 | -$2.47M derived: sum of 4 quarters · filed 2024-12-13 |
| 2023-07-31 | $342.96K 10-Q · filed 2024-09-17 | $54.57K derived: sum of 2 quarters · filed 2024-09-17 | -$487.13K derived: sum of 3 quarters · filed 2024-09-17 | -$2.37M derived: sum of 4 quarters · filed 2024-09-17 |
| 2023-04-30 | -$288.39K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-13 | -$830.09K derived: sum of 2 quarters · filed 2024-08-13 | -$2.71M derived: sum of 3 quarters · filed 2024-08-13 | -$3.79M 10-K · filed 2024-08-13 |
| 2023-01-31 | -$541.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-18 | -$2.42M derived: sum of 2 quarters · filed 2024-03-18 | -$3.51M 10-Q · filed 2024-03-18 | -$4.70M derived: sum of 4 quarters · filed 2024-03-18 |
| 2022-10-31 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15 | -$2.96M 10-Q · filed 2023-12-15 | -$4.16M derived: sum of 3 quarters · filed 2023-12-15 | -$4.45M derived: sum of 4 quarters · filed 2023-12-15 |
| 2022-07-31 | -$1.08M 10-Q · filed 2023-09-18 | -$2.28M derived: sum of 2 quarters · filed 2023-09-18 | -$2.57M derived: sum of 3 quarters · filed 2023-09-18 | -$3.96M derived: sum of 4 quarters · filed 2023-09-18 |
| 2022-04-30 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | -$1.49M derived: sum of 2 quarters · filed 2023-07-31 | -$2.88M derived: sum of 3 quarters · filed 2023-07-31 | -$4.12M 10-K · filed 2023-07-31 |
| 2022-01-31 | -$298.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | -$1.68M derived: sum of 2 quarters · filed 2023-03-16 | -$2.93M 10-Q · filed 2023-03-16 | -$3.87M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-10-31 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-14 | -$2.63M 10-Q · filed 2022-12-14 | -$3.57M derived: sum of 3 quarters · filed 2022-12-14 | -$4.16M derived: sum of 4 quarters · filed 2022-12-14 |
| 2021-07-31 | -$1.24M 10-Q · filed 2022-09-14 | -$2.18M derived: sum of 2 quarters · filed 2022-09-14 | -$2.77M derived: sum of 3 quarters · filed 2022-09-14 | -$4.02M derived: sum of 4 quarters · filed 2022-09-14 |
| 2021-04-30 | -$940.30K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | -$1.53M derived: sum of 2 quarters · filed 2022-07-28 | -$2.78M derived: sum of 3 quarters · filed 2022-07-28 | -$3.33M 10-K · filed 2022-07-28 |
| 2021-01-31 | -$589.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | -$1.84M derived: sum of 2 quarters · filed 2022-03-15 | -$2.39M 10-Q · filed 2022-03-15 | -$3.03M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-10-31 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-14 | -$1.80M 10-Q · filed 2021-12-14 | -$2.44M derived: sum of 3 quarters · filed 2021-12-14 | -$2.79M derived: sum of 4 quarters · filed 2021-12-14 |
| 2020-07-31 | -$551.00K 10-Q · filed 2021-09-14 | -$1.19M derived: sum of 2 quarters · filed 2021-09-14 | -$1.54M derived: sum of 3 quarters · filed 2021-09-14 | -$2.13M derived: sum of 4 quarters · filed 2021-09-14 |
| 2020-04-30 | -$639.39K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | -$991.61K derived: sum of 2 quarters · filed 2021-08-10 | -$1.58M derived: sum of 3 quarters · filed 2021-08-10 | -$2.34M 10-K · filed 2021-08-10 |
| 2020-01-31 | -$352.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-12 | -$935.84K derived: sum of 2 quarters · filed 2021-03-12 | -$1.70M 10-Q · filed 2021-03-12 | -$2.36M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-10-31 | -$583.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-11 | -$1.35M 10-Q · filed 2020-12-11 | -$2.01M derived: sum of 3 quarters · filed 2020-12-11 | -$2.68M derived: sum of 4 quarters · filed 2020-12-11 |
| 2019-07-31 | -$763.14K 10-Q · filed 2020-09-11 | -$1.42M derived: sum of 2 quarters · filed 2020-09-11 | -$2.10M derived: sum of 3 quarters · filed 2020-09-11 | -$3.02M derived: sum of 4 quarters · filed 2020-09-11 |
| 2019-04-30 | -$661.36K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | -$1.34M derived: sum of 2 quarters · filed 2020-08-13 | -$2.26M derived: sum of 3 quarters · filed 2020-08-13 | -$2.88M 10-K · filed 2020-08-13 |
| 2019-01-31 | -$676.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-13 | -$1.59M derived: sum of 2 quarters · filed 2020-03-13 | -$2.22M 10-Q · filed 2020-03-13 | -$3.59M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-10-31 | -$917.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-23 | -$1.54M 10-Q · filed 2019-12-23 | -$2.91M derived: sum of 3 quarters · filed 2019-12-23 | -$4.09M derived: sum of 4 quarters · filed 2019-12-23 |
| 2018-07-31 | -$622.24K 10-Q · filed 2019-09-13 | -$2.00M derived: sum of 2 quarters · filed 2019-09-13 | -$3.17M derived: sum of 3 quarters · filed 2019-09-13 | -$4.77M derived: sum of 4 quarters · filed 2019-09-13 |
| 2018-04-30 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | -$2.55M derived: sum of 2 quarters · filed 2019-08-13 | -$4.14M derived: sum of 3 quarters · filed 2019-08-13 | -$5.08M 10-K · filed 2019-08-13 |
| 2018-01-31 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-14 | -$2.77M derived: sum of 2 quarters · filed 2019-03-14 | -$3.70M 10-Q · filed 2019-03-14 | -$4.51M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-10-31 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-14 | -$2.53M 10-Q · filed 2018-12-14 | -$3.33M derived: sum of 3 quarters · filed 2018-12-14 | -$4.26M derived: sum of 4 quarters · filed 2018-12-14 |
| 2017-07-31 | -$935.57K 10-Q · filed 2018-09-12 | -$1.74M derived: sum of 2 quarters · filed 2018-09-12 | -$2.66M derived: sum of 3 quarters · filed 2018-09-12 | -$3.37M derived: sum of 4 quarters · filed 2018-09-12 |
| 2017-04-30 | -$800.89K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-20 | -$1.73M derived: sum of 2 quarters · filed 2018-07-20 | -$2.43M derived: sum of 3 quarters · filed 2018-07-20 | -$3.34M 10-K · filed 2018-07-20 |
| 2017-01-31 | -$925.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | -$1.63M derived: sum of 2 quarters · filed 2018-03-19 | -$2.54M 10-Q · filed 2018-03-19 | |
| 2016-10-31 | -$706.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-14 | -$1.61M 10-Q · filed 2017-12-14 | ||
| 2016-07-31 | -$906.93K 10-Q · filed 2017-09-13 | |||
| 2013-10-31 | -$207.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | -$366.77K 10-Q · filed 2013-12-16 | -$509.72K derived: sum of 3 quarters · filed 2013-12-16 | -$587.32K derived: sum of 4 quarters · filed 2013-12-16 |
| 2013-07-31 | -$159.67K 10-Q · filed 2013-09-16 | -$302.63K derived: sum of 2 quarters · filed 2013-09-16 | -$380.22K derived: sum of 3 quarters · filed 2013-09-16 | -$464.71K derived: sum of 4 quarters · filed 2013-12-16 |
| 2013-04-30 | -$142.95K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | -$220.55K derived: sum of 2 quarters · filed 2013-07-29 | -$305.04K derived: sum of 3 quarters · filed 2013-12-16 | -$390.43K 10-K · filed 2013-07-29 |
| 2013-01-31 | -$77.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | -$162.09K derived: sum of 2 quarters · filed 2013-12-16 | -$247.47K 10-Q · filed 2013-03-26 | -$299.43K derived: sum of 4 quarters · filed 2013-12-16 |
| 2012-10-31 | -$84.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | -$169.88K 10-Q · filed 2013-12-16 | -$221.84K derived: sum of 3 quarters · filed 2013-12-16 | -$257.97K derived: sum of 4 quarters · filed 2013-12-16 |
| 2012-07-31 | -$85.39K 10-Q · filed 2013-09-16 | -$137.34K derived: sum of 2 quarters · filed 2013-09-16 | -$173.48K derived: sum of 3 quarters · filed 2013-09-16 | -$225.05K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-04-30 | -$51.95K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | -$88.09K derived: sum of 2 quarters · filed 2013-07-29 | -$139.66K derived: sum of 3 quarters · filed 2013-07-29 | -$259.29K 10-K · filed 2013-07-29 |
| 2012-01-31 | -$36.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | -$87.71K derived: sum of 2 quarters · filed 2013-03-26 | -$207.33K 10-Q · filed 2013-03-26 | -$349.20K derived: sum of 4 quarters · filed 2013-03-26 |
| 2011-10-31 | -$51.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-26 | -$171.19K 10-Q · filed 2012-12-26 | -$313.07K derived: sum of 3 quarters · filed 2012-12-26 | -$381.98K derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-07-31 | -$119.63K 10-Q · filed 2012-09-19 | -$261.50K derived: sum of 2 quarters · filed 2012-09-19 | -$330.41K derived: sum of 3 quarters · filed 2012-09-19 | -$331.69K derived: sum of 4 quarters · filed 2012-09-19 |
| 2011-04-30 | -$141.87K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | -$210.79K derived: sum of 2 quarters · filed 2012-08-14 | -$212.06K derived: sum of 3 quarters · filed 2012-08-14 | -$225.23K 10-K · filed 2012-08-14 |
| 2011-01-31 | -$68.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-21 | -$70.19K derived: sum of 2 quarters · filed 2012-03-21 | -$83.36K 10-Q · filed 2012-03-21 | |
| 2010-10-31 | -$1.28K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-12-15 | -$14.45K 10-Q · filed 2011-12-15 | ||
| 2010-07-31 | -$13.17K 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |